Allogeneic cytotoxic T lymphocytes can mediate graft-versus-leukemia without causing graft-versus-host disease.

被引：0
|
作者：
Boyer, MW
Johnson, TS
Yeager, AM
Waller, EK
机构：
[1] EMORY UNIV,DEPT PEDIAT,ATLANTA,GA 30322
[2] EMORY UNIV,DEPT MED,ATLANTA,GA 30322
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：964 / 964
页数：1
相关论文
共 50 条
  • [21] Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
    Li, Jian-Ming
    Giver, Cynthia R.
    Lu, Ying
    Hossain, Mohammad S.
    Akhtari, Mojtaba
    Waller, Edmund K.
    IMMUNOTHERAPY, 2009, 1 (04) : 599 - 621
  • [22] gamma delta T cells prevent allogeneic marrow graft rejection in mice without causing graft-versus-host disease.
    Drobyski, WR
    Majewski, D
    BLOOD, 1995, 86 (10) : 2275 - 2275
  • [23] Preventing Graft-Versus-Host Disease Without Losing Graft-Versus-Leukemia Effect After Allogeneic Stem-Cell Transplantation
    Kroeger, Nicolaus
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29) : 3357 - 3360
  • [24] β2 INTERGRINS SEPARATES GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA EFFECT
    Yu, X. -Z
    Liang, Y.
    Lin, C.
    Djeu, J. Y.
    Zhong, B.
    Peters, T.
    Scharffetter-Kochanek, K.
    Anasetti, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 139 - 139
  • [25] Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion
    Porter, D
    Levine, JE
    SEMINARS IN HEMATOLOGY, 2006, 43 (01) : 53 - 61
  • [26] Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity
    Stenger, Elizabeth O.
    Turnquist, Heth R.
    Mapara, Markus Y.
    Thomson, Angus W.
    BLOOD, 2012, 119 (22) : 5088 - 5103
  • [27] β2 integrins separate graft-versus-host disease and graft-versus-leukemia effects
    Liang, Yaming
    Liu, Chen
    Djeu, Julie Y.
    Zhong, Bin
    Peters, Thorsten
    Scharffetter-Kochanek, Karin
    Anasetti, Claudio
    Yu, Xue-Zhong
    BLOOD, 2008, 111 (02) : 954 - 962
  • [28] GRAFT-VERSUS-LEUKEMIA WITHOUT GRAFT-VERSUS-HOST DISEASE - AN ELUSIVE GOAL OF BONE-MARROW TRANSPLANTATION
    CHAMPLIN, R
    SEMINARS IN HEMATOLOGY, 1992, 29 (03) : 46 - 52
  • [29] RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE - RELATIONSHIP BETWEEN GRAFT-VERSUS-HOST AND GRAFT-VERSUS-LEUKEMIA REACTION
    JACOBSEN, N
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 579 - 579
  • [30] In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
    Choi, Jaebok
    Ritchey, Julie
    Prior, Julie L.
    Holt, Matthew
    Shannon, William D.
    Deych, Elena
    Piwnica-Worms, David R.
    DiPersio, John F.
    BLOOD, 2010, 116 (01) : 129 - 139
12345